These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8848890)

  • 21. Factors predicting atracurium reversal time.
    Kirkegaard-Nielsen H; Severinsen IK; Pedersen HS; Lindholm P
    Acta Anaesthesiol Scand; 1999 Sep; 43(8):834-41. PubMed ID: 10492412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
    Stevens JB; Walker SC; Fontenot JP
    Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonism of profound neuromuscular blockade induced by vecuronium or atracurium. Comparison of neostigmine with edrophonium.
    Caldwell JE; Robertson EN; Baird WL
    Br J Anaesth; 1986 Nov; 58(11):1285-9. PubMed ID: 2877681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonism of atracurium-induced neuromuscular blockade by neostigmine or edrophonium.
    Astley BA; Hughes R; Payne JP
    Br J Anaesth; 1986 Nov; 58(11):1290-5. PubMed ID: 3778793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neostigmine but not edrophonium prolongs the action of mivacurium.
    Symington MJ; Mirakhur RK; Kumar N
    Can J Anaesth; 1996 Dec; 43(12):1220-3. PubMed ID: 8955970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The maximum depth of an atracurium neuromuscular block antagonized by edrophonium to effect adequate recovery.
    Beemer GH; Goonetilleke PH; Bjorksten AR
    Anesthesiology; 1995 Apr; 82(4):852-8. PubMed ID: 7717555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the neuromuscular blocking effects and reversibility of cisatracurium and atracurium.
    Carroll MT; Mirakhur RK; Lowry D; Glover P; Kerr CJ
    Anaesthesia; 1998 Aug; 53(8):744-8. PubMed ID: 9797517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
    Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of intense neuromuscular blockade following infusion of atracurium.
    Engbaek J; Ostergaard D; Skovgaard LT; Viby-Mogensen J
    Anesthesiology; 1990 May; 72(5):803-6. PubMed ID: 2160206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profound atracurium induced neuromuscular blockade. A comparison of evoked reversal with edrophonium or neostigmine.
    Casson WR; Jones RM
    Anaesthesia; 1986 Apr; 41(4):382-5. PubMed ID: 3754698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzymatic versus pharmacologic antagonism of profound mivacurium- induced neuromuscular blockade.
    Naguib M; Selim M; Bakhamees HS; Samarkandi AH; Turkistani A
    Anesthesiology; 1996 May; 84(5):1051-9. PubMed ID: 8623998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults.
    Abdulatif M; Mowafi H; al-Ghamdi A; el-Sanabary M
    Br J Anaesth; 1996 Dec; 77(6):710-5. PubMed ID: 9014620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of verapamil with atracurium and reversal of combined neuromuscular blockade with edrophonium and neostigmine.
    Wali FA; McAteer E; Suer AH
    Ir J Med Sci; 1987 Jul; 156(7):215-8. PubMed ID: 3654161
    [No Abstract]   [Full Text] [Related]  

  • 34. Determinants of the reversal time of competitive neuromuscular block by anticholinesterases.
    Beemer GH; Bjorksten AR; Dawson PJ; Dawson RJ; Heenan PJ; Robertson BA
    Br J Anaesth; 1991 Apr; 66(4):469-75. PubMed ID: 2025474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neostigmine and edrophonium antagonism of moderate neuromuscular block induced by pancuronium or tubocurarine.
    Shorten GD; Ali HH; Goudsouzian NG
    Br J Anaesth; 1993 Feb; 70(2):160-2. PubMed ID: 8435259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimum dose of neostigmine at two levels of atracurium-induced neuromuscular block.
    Harper NJ; Wallace M; Hall IA
    Br J Anaesth; 1994 Jan; 72(1):82-5. PubMed ID: 8110558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antagonism of alcuronium with edrophonium or neostigmine.
    Harper NJ; Bradshaw EG; Healy TE
    Br J Anaesth; 1984 Oct; 56(10):1089-94. PubMed ID: 6089857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spontaneous versus edrophonium-induced recovery from paralysis with mivacurium.
    Brandom BW; Taiwo OO; Woelfel SK; Schön H; Gronert BJ; Cook DR
    Anesth Analg; 1996 May; 82(5):999-1002. PubMed ID: 8610913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spontaneous recovery or evoked reversal of neuromuscular block.
    Mirakhur RK
    Acta Anaesthesiol Scand Suppl; 1995; 106():62-5. PubMed ID: 8533549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose responses for neostigmine and edrophonium as antagonists of mivacurium in adults and children.
    Bevan JC; Tousignant C; Stephenson C; Blackman L; Reimer E; Smith MF; Bevan DR
    Anesthesiology; 1996 Feb; 84(2):354-61. PubMed ID: 8602666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.